Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 36, 2023 - Issue 1
Submit an article Journal homepage
7,655
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Elevated liver enzymes and adverse outcomes among patients with preeclampsia with severe features

Karen S. Greinera Department of Obstetrics and Gynecology, Kaiser Permanente San Francisco, San Francisco, CA, USACorrespondence[email protected]
View further author information
,
Mónica Rincónb Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USAView further author information
,
Kelli L. Derrahc Department of Pediatrics, University of California, Davis, Davis, CA, USAView further author information
&
Richard M. Burwickd San Gabriel Valley Perinatal Medical Group, Division of Maternal Fetal Medicine, Pomona Valley Hospital Medical Center, Pomona, CA, USAView further author information
Article: 2160627 | Received 09 Sep 2022, Accepted 14 Dec 2022, Published online: 04 Jan 2023

References

  • Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121 Suppl 1:14–24.
  • Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367(9516):1066–1074.
  • Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980–2010: age-period-cohort analysis. BMJ. 2013;347:f6564.
  • ACOG Practice Bulletin No 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):e1–e25.
  • Demir SC, Evruke C, Ozgunen FT, et al. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J. 2006;27(7):1015–1018.
  • Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000;95(1):24–28.
  • Kozic JR, Benton SJ, Hutcheon JA, et al. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(10):995–1004.
  • Martin JN, Jr., May WL, Magann EF, et al. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol. 1999;180(6 Pt 1):1407–1414.
  • Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000–1006.
  • Sibai BM, Taslimi MM, el-Nazer A, et al. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol. 1986;155(3):501–509.
  • Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982;142(2):159–167.
  • American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.